Register now!

Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

In vivo, in vitro, in silico: Why computer modelling is the next evolution of the healthcare sector

International Conference on In Silico Medicine on 4 September

find out more ›

Cipla brings India perspectives on In Silico to Brussels

New Avicenna Member company Cipla shared some key insights on India’s perspective of In Silico medicine during a visit to Brussels in April....

find out more ›

Enabling the digital transformation of health and care in the EU

The European Commission presented its views on e-health and proposed a set of measures to facilitate the digital transformation of...

find out more ›

Show all activites